Humana CenterWell — Net loss (income) attributable to noncontrolling interests remained flat by 0.0% to $250.00K in Q4 2023 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $250.00K to $250.00K. Over 2 years (FY 2021 to FY 2023), CenterWell — Net loss (income) attributable to noncontrolling interests shows relatively stable performance with a 0.0% CAGR.
Positive values indicate minority partners are sharing in the segment's profits, while negative values reflect their share of losses.
Indicates the net profit or loss of the CenterWell segment that is allocated to minority owners. This reflects the finan...
Standard accounting line item for segments with non-wholly owned subsidiaries.
hum_segment_centerwell_net_loss_income_attributable_to_noncontrolling_interests| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $1.00M | $1.00M | $1.00M |
| YoY Change | — | +0.0% | +0.0% |